|
1
|
Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study.
|
Eur Urol
|
2009
|
2.80
|
|
2
|
The value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer.
|
Eur Urol
|
2007
|
2.77
|
|
3
|
A molecular taxonomy for urothelial carcinoma.
|
Clin Cancer Res
|
2012
|
2.37
|
|
4
|
Urinary bladder cancer treated with radical cystectomy: perioperative parameters and early complications prospectively registered in a national population-based database.
|
Scand J Urol
|
2014
|
2.07
|
|
5
|
MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31.
|
Int J Cancer
|
2009
|
2.06
|
|
6
|
Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome.
|
Cancer Res
|
2010
|
1.99
|
|
7
|
Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma.
|
PLoS One
|
2012
|
1.56
|
|
8
|
Simplified intraoperative sentinel-node detection performed by the urologist accurately determines lymph-node stage in prostate cancer.
|
Scand J Urol
|
2014
|
1.38
|
|
9
|
Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors.
|
BMC Med Genomics
|
2008
|
1.24
|
|
10
|
A systematic study of gene mutations in urothelial carcinoma; inactivating mutations in TSC2 and PIK3R1.
|
PLoS One
|
2011
|
1.21
|
|
11
|
DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status.
|
Epigenetics
|
2012
|
1.07
|
|
12
|
Toward a molecular pathologic classification of urothelial carcinoma.
|
Am J Pathol
|
2013
|
1.03
|
|
13
|
Distinct mitotic segregation errors mediate chromosomal instability in aggressive urothelial cancers.
|
Clin Cancer Res
|
2007
|
0.99
|
|
14
|
Recurrent and multiple bladder tumors show conserved expression profiles.
|
BMC Cancer
|
2008
|
0.89
|
|
15
|
Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
|
BJU Int
|
2012
|
0.86
|
|
16
|
Can tissue microarray-based analysis of protein expression predict recurrence of stage Ta bladder cancer?
|
Scand J Urol Nephrol
|
2011
|
0.86
|
|
17
|
Use of bacillus Calmette-Guérin in stage T1 bladder cancer: Long-term observation of a population-based cohort.
|
Scand J Urol
|
2014
|
0.83
|
|
18
|
A population-based study of patterns of care for muscle-invasive bladder cancer in Sweden.
|
Scand J Urol Nephrol
|
2009
|
0.82
|
|
19
|
Extended pelvic lymphadenectomy for prostate cancer: will the previously reported benefits be reproduced in hospitals with lower surgical volumes?
|
Scand J Urol Nephrol
|
2009
|
0.82
|
|
20
|
Impact of hospital volume on local recurrence and distant metastasis in bladder cancer patients treated with radical cystectomy in Sweden.
|
Scand J Urol
|
2013
|
0.79
|
|
21
|
The value of bladder mapping and prostatic urethra biopsies for detection of carcinoma in situ (CIS).
|
BJU Int
|
2011
|
0.78
|
|
22
|
Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference?
|
World J Urol
|
2009
|
0.78
|
|
23
|
Urinary diversion after cystectomy for bladder cancer: a population-based study in Sweden.
|
Scand J Urol Nephrol
|
2010
|
0.78
|
|
24
|
[(18)F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy.
|
Scand J Urol
|
2015
|
0.76
|
|
25
|
[Can urologists learn to perform testicular color doppler ultrasonography?].
|
Lakartidningen
|
2005
|
0.75
|
|
26
|
Re: Richard J. Sylvester, Willem Oosterlinck. An immediate instillation after transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: has the evidence changed? Eur Urol 2009;56;43-5.
|
Eur Urol
|
2009
|
0.75
|
|
27
|
Re: the predictors of pelvic lymph node metastasis at radical retropubic prostatectomy.
|
J Urol
|
2004
|
0.75
|
|
28
|
Re: Bilateral laparoscopic inguinal hernia repair can complicate subsequent radical retropubic prostatecomy.
|
J Urol
|
2002
|
0.75
|
|
29
|
Re: Hervé Baumert, Andrew Ballaro, Carlos Arroyo, Amir V. Kaisary, Peter F.A. Mulders and Ben C. Knipscheer. The use of polymer (Hem-o-lok) clips for management of the renal hilum during laparoscopic nephrectomy. Eur Urol 2006;49:816-9.
|
Eur Urol
|
2006
|
0.75
|
|
30
|
Editorial comment on: Ischemic renal damage after nephron-sparing surgery in patients with normal contralateral kidney.
|
Eur Urol
|
2008
|
0.75
|
|
31
|
The importance of being grade 3: WHO 1999 versus WHO 2004 pathologic grading.
|
Eur Urol
|
2012
|
0.75
|
|
32
|
[In Process Citation].
|
Lakartidningen
|
2016
|
0.75
|
|
33
|
Arterial bleeding during transurethral resection of bladder cancer managed by endovascular intervention.
|
Urol Int
|
2012
|
0.75
|